Durable effect of pyrotinib plus capecitabine in HER-2+ breast cancer patient undergoing peritoneal dialysis: A case report and literature review

For patients with end-stage renal disease (ESRD), peritoneal dialysis (PD) and hemodialysis (HD) are important renal replacement treatments. Patients on dialysis usually have a high incidence rate of malignant tumors. In 2020, breast cancer has become the malignant tumor with the highest incidence r...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xiangting, Yan, Min, Li, Fanfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780055/
https://www.ncbi.nlm.nih.gov/pubmed/36568221
http://dx.doi.org/10.3389/fonc.2022.1059670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780055/
https://www.ncbi.nlm.nih.gov/pubmed/36568221
http://dx.doi.org/10.3389/fonc.2022.1059670

Ejemplares similares